Technology News and Research

RSS

Legislation that slows human embryonic stem cell research will also harm iPS cells study

Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan.

10 Jun 2011

IMS Health acquires Med-Vantage

IMS Health has acquired Med-Vantage, a San Francisco-based software solutions company, to further expand its presence and capabilities in the payer marketplace. Med-Vantage offers its clients a comprehensive suite of provider performance management and member engagement solutions that promote high-quality care and address the complexities of new reimbursement and care delivery models.

10 Jun 2011

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company, and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), components of the National Institutes of Health.

10 Jun 2011

Large medical groups urge OMB to be careful with ACO budget expectations

The American Group Management Association asked the Obama administration to scale back the anticipated savings that are expected from the creation of accountable care organizations. Setting the savings bar too high, the organizations said, could cause the ACO program to be unsuccessful.

10 Jun 2011

NIOSH grants Noveko N95 certification for RD5-V respirator

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has obtained N95 certification from the U.S. National Institute for Occupational Safety and Health ("NIOSH") for its Noveko RD5-V respirator.

10 Jun 2011

Revance closes $45 million financing

Revance Therapeutics, Inc. today announced the closing of a $45 million financing led by Essex Woodlands Health Ventures and new investor, NovaQuest Capital.

10 Jun 2011

Life Technologies enters exclusive agreement for TAL Effector Technology license

Life Technologies Corporation has signed an exclusive license agreement for novel technology that enables synthetic biologists to effectively program and control the genetic circuitry in engineered pathways and organisms.

10 Jun 2011

Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences (Ambit), an emerging biopharmaceutical company engaged in the development of kinase inhibitors for the treatment of cancer and other conditions, today announced that it has completed a Series D-2 round of equity financing, raising $30 million in new capital.

10 Jun 2011

Spanish scale measures concern about cancer in healthy people

When a person has a family history of cancer, their worry about developing the disease may lead to them refusing to have preventive tests. Advice from genetic counselling units reduces their anxiety but, until now, nobody knew how much. Now, a scientific team has validated the 'Escala de Preocupaci-n por el C-ncer - EPC' (equivalent of the Cancer Worry Scale), the first of its kind in the Spanish language, in order to evaluate it.

10 Jun 2011

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

Luminex Corporation and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli infection.

From Luminex 10 Jun 2011

CMSRU earns Liaison Committee on Medical Education preliminary accreditation

Almost two years after officials announced its creation, Cooper Medical School of Rowan University (CMSRU) has received the go-ahead to recruit students for the charter class - entering in the fall of 2012.

10 Jun 2011

Study links mutations in essential genes with orphan diseases

Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics.

10 Jun 2011

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.

10 Jun 2011

Ban calls for global unity to end AIDS by 2020 at U.N. meeting opening

In his opening address at the U.N. High Level Meeting on AIDS on Wednesday, U.N. Secretary-General Ban Ki-moon "told presidents, ministers and diplomats from across the globe that if all partners involved in the fight unite 'as never before,'" the goal of "zero new infections, zero stigma and zero AIDS-related deaths" can be achieved, the Associated Press/Kansas City Star reports.

10 Jun 2011

Scientists to develop new tissue engineering technology for patients with osteoarthritis

Medical scientists now have "clear" evidence that the damaged cartilage tissue in osteoarthritis and other painful joint disorders can be encouraged to regrow and regenerate, and are developing tissue engineering technology that could help millions of patients with those disorders.

10 Jun 2011

Researchers develop new imaging technology to detect cardiovascular disease

Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser.

10 Jun 2011

Schepens, Mass. Eye and Ear to create world's largest ophthalmology research center

The Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute announced today that they are combining forces to create the world's largest and most robust basic and clinical ophthalmology research enterprise with full spectrum bench-to-bedside research that will translate more quickly into better treatment for blinding diseases and ultimately cures.

10 Jun 2011

Tucson Medical Center, local physicians create nation's first 'Sustainable Health Community'

Tucson Medical Center and local physicians, with the help of health technology and services company Optum, today announced they are creating the nation's first "Sustainable Health Community," based on an Accountable Care Organization (ACO) model in which hospitals, physicians, residents, employers and others share in the risk and rewards of making the health system work better for everyone.

10 Jun 2011

Quest Diagnostics receives MDEA gold award for Simplexa/3M technology

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that its Simplexa molecular diagnostic test on the 3M Integrated Cycler won a gold award in the in vitro diagnostics category at the 2011 MDEA awards ceremony yesterday in New York City.

From Quest Diagnostics 10 Jun 2011

Non-alcoholic wheat beer has positive effect on athletes' health

Many amateur athletes have long suspected what research scientists for the Department of Preventative and Rehabilitative Sports Medicine of the Technische Universitaet Muenchen at Klinikum rechts der Isar have now made official: Documented proof, gathered during the world's largest study of marathons, "Be-MaGIC", that the consumption of non-alcoholic weissbier, or wheat beer, has a positive effect on athletes' health.

10 Jun 2011

Technology News and Research

Legislation that slows human embryonic stem cell research will also harm iPS cells study

IMS Health acquires Med-Vantage

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

Large medical groups urge OMB to be careful with ACO budget expectations

NIOSH grants Noveko N95 certification for RD5-V respirator

Revance closes $45 million financing

Life Technologies enters exclusive agreement for TAL Effector Technology license

Ambit Biosciences raises $30 million through Series D-2 equity financing

Spanish scale measures concern about cancer in healthy people

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

CMSRU earns Liaison Committee on Medical Education preliminary accreditation

Study links mutations in essential genes with orphan diseases

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

Ban calls for global unity to end AIDS by 2020 at U.N. meeting opening

Scientists to develop new tissue engineering technology for patients with osteoarthritis

Researchers develop new imaging technology to detect cardiovascular disease

Schepens, Mass. Eye and Ear to create world's largest ophthalmology research center

Tucson Medical Center, local physicians create nation's first 'Sustainable Health Community'

Quest Diagnostics receives MDEA gold award for Simplexa/3M technology

Non-alcoholic wheat beer has positive effect on athletes' health

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News